Laboratory Short Long Term Debt Total vs Other Stockholder Equity Analysis
LH Stock | USD 194.91 1.47 0.76% |
Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Short Long Term Debt Total and its Other Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Short Long Term Debt Total vs Other Stockholder Equity
Short Long Term Debt Total vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Short Long Term Debt Total account and Other Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Laboratory's Short Long Term Debt Total and Other Stockholder Equity is 0.52. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Short Long Term Debt Total and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Laboratory of are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Short Long Term Debt Total i.e., Laboratory's Short Long Term Debt Total and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.52 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Short Long Term Debt Total
Other Stockholder Equity
Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's Tax Provision is increasing as compared to previous years. The Laboratory's current Enterprise Value is estimated to increase to about 7.8 B, while Selling General Administrative is projected to decrease to under 1.1 B.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.6B | 4.4B | 3.1B | 1.9B | Total Revenue | 16.1B | 14.9B | 12.2B | 12.8B |
Laboratory fundamental ratios Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 98.6M | 98M | 97.5M | 91.6M | 87.6M | 96.0M | |
Total Assets | 18.0B | 20.1B | 20.4B | 20.2B | 16.7B | 17.6B | |
Other Current Liab | 942.4M | 1.4B | 1.4B | 1.1B | 804M | 502.9M | |
Total Current Liabilities | 1.9B | 2.6B | 3.1B | 2.8B | 3.2B | 3.4B | |
Total Stockholder Equity | 7.6B | 9.4B | 10.3B | 10.1B | 7.9B | 8.3B | |
Property Plant And Equipment Net | 2.6B | 2.7B | 2.8B | 3.0B | 2.9B | 3.1B | |
Net Debt | 6.7B | 5.4B | 4.9B | 5.9B | 5.4B | 5.7B | |
Retained Earnings | 7.9B | 9.4B | 10.5B | 10.6B | 7.9B | 8.3B | |
Accounts Payable | 632.3M | 638.9M | 621.3M | 934.8M | 827.5M | 868.9M | |
Cash | 337.5M | 1.3B | 1.5B | 430M | 536.8M | 290.8M | |
Non Current Assets Total | 15.0B | 14.9B | 15.1B | 15.5B | 13.0B | 13.6B | |
Non Currrent Assets Other | 435.4M | 410M | 462.6M | 432.7M | 536.5M | 270.8M | |
Cash And Short Term Investments | 337.5M | 1.3B | 1.5B | 430M | 536.8M | 299.7M | |
Net Receivables | 2.0B | 3.0B | 3.0B | 3.0B | 2.1B | 2.2B | |
Liabilities And Stockholders Equity | 18.0B | 20.1B | 20.4B | 20.2B | 16.7B | 17.6B | |
Non Current Liabilities Total | 7.8B | 7.6B | 7.3B | 7.0B | 5.6B | 3.1B | |
Other Current Assets | 373.7M | 364.8M | 478.1M | 707M | 655.3M | 688.1M | |
Other Stockholder Equity | 26.8M | 110.3M | (192M) | (493.2M) | 38.4M | 36.5M | |
Total Liab | 10.5B | 10.7B | 10.1B | 10.1B | 8.8B | 9.3B | |
Total Current Assets | 3.0B | 5.1B | 5.3B | 4.6B | 3.8B | 4.0B | |
Short Long Term Debt Total | 7.1B | 6.8B | 6.3B | 6.3B | 6.0B | 6.3B | |
Intangible Assets | 4.0B | 4.0B | 3.7B | 3.9B | 3.3B | 2.0B | |
Short Term Debt | 621.1M | 575.4M | 199M | 492.8M | 1.2B | 1.2B | |
Inventory | 244.7M | 423.2M | 401.4M | 470.6M | 474.6M | 498.3M | |
Property Plant And Equipment Gross | 2.6B | 2.7B | 5.2B | 5.7B | 5.8B | 6.1B | |
Accumulated Other Comprehensive Income | (372.4M) | (161.9M) | (192M) | (493.2M) | (59.3M) | (62.3M) | |
Other Liab | 1.3B | 1.4B | 1.2B | 1.1B | 1.2B | 702.7M | |
Other Assets | 356.5M | 350.9M | 484.2M | 440.3M | 506.3M | 531.7M | |
Long Term Debt | 5.8B | 5.4B | 5.4B | 5.0B | 4.1B | 3.1B | |
Property Plant Equipment | 2.7B | 2.8B | 2.8B | 3.0B | 3.4B | 3.6B | |
Good Will | 7.9B | 7.8B | 8.0B | 8.1B | 6.1B | 4.4B | |
Current Deferred Revenue | 451M | 506.5M | 558.5M | 582.1M | 421.7M | 442.8M | |
Net Tangible Assets | (4.3B) | (2.4B) | (1.4B) | (2.0B) | (1.8B) | (1.9B) | |
Long Term Debt Total | 5.9B | 5.5B | 5.5B | 5.1B | 5.9B | 4.8B |
Currently Active Assets on Macroaxis
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.123 | Dividend Share 2.88 | Earnings Share 4.68 | Revenue Per Share 142.986 | Quarterly Revenue Growth 0.046 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.